JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4951
Red River Bancshares
RRBI
$684M
| $161K | ﹤0.01% |
3,340
-120
| -3% | -$5.94K |
2019 Q2
15 quarters
|
|
|
PAMT
4952
PAMT Corp
PAMT
$245M
| $161K | ﹤0.01% |
5,598
-419
| -7% | -$11.8K |
2016 Q4
25 quarters
|
|
4953
Granite Ridge Resources
GRNT
$604M
| $160K | ﹤0.01% |
+27,267
| New | +$184K |
2023 Q1
0 quarters
|
|
|
AY
4954
PUT
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $160K | ﹤0.01% |
+5,400
| New | +$147K |
2023 Q1
0 quarters
|
|
4955
BlackRock Core Bond Trust
BHK
$584M
| $159K | ﹤0.01% |
14,658
+14,640
| +81,333% | +$161K |
2022 Q4
1 quarter
|
|
4956
Kodiak Sciences
KOD
$5.92B
| $159K | ﹤0.01% |
25,725
-87,148
| -77% | -$610K |
2018 Q4
17 quarters
|
|
4957
First Trust Low Duration Strategic Focus ETF
LDSF
$161M
| $159K | ﹤0.01% |
8,561
+7,658
| +848% | +$142K |
2022 Q4
1 quarter
|
|
4958
Prime Medicine
PRME
$635M
| $159K | ﹤0.01% |
12,897
+3,023
| +31% | +$49.2K |
2022 Q4
1 quarter
|
|
|
TRUE
4959
DELISTED
TrueCar
TRUE
| $159K | ﹤0.01% |
69,078
+18,907
| +38% | +$50.4K |
2016 Q4
25 quarters
|
|
4960
Orange County Bancorp
OBT
$508M
| $158K | ﹤0.01% |
+7,200
| New | +$180K |
2023 Q1
0 quarters
|
|
|
AKTS
4961
DELISTED
Akoustis Technologies Inc
AKTS
| $158K | ﹤0.01% |
51,158
+21,487
| +72% | +$75K |
2019 Q2
15 quarters
|
|
|
HYZN
4962
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $158K | ﹤0.01% |
3,869
+973
| +34% | +$72.5K |
2021 Q1
8 quarters
|
|
|
AXON
4963
PUT
Axon Enterprise
AXON
$34.1B
| $157K | ﹤0.01% |
+700
| New | +$139K |
2023 Q1
0 quarters
|
|
4964
Century Casinos
CNTY
$29M
| $157K | ﹤0.01% |
21,400
+5,884
| +38% | +$49.1K |
2017 Q4
21 quarters
|
|
4965
Humacyte
HUMA
$141M
| $157K | ﹤0.01% |
50,978
+13,676
| +37% | +$38.9K |
2021 Q4
5 quarters
|
|
4966
Rimini Street
RMNI
$388M
| $157K | ﹤0.01% |
38,200
-42,951
| -53% | -$193K |
2018 Q2
19 quarters
|
|
4967
Workhorse Group
WKHS
$32.3M
| $157K | ﹤0.01% |
39
+10
| +34% | +$55.2K |
2020 Q2
11 quarters
|
|
4968
Atlanticus Holdings
ATLC
$1.43B
| $156K | ﹤0.01% |
5,750
+837
| +17% | +$25.2K |
2020 Q2
11 quarters
|
|
|
DOYU
4969
DouYu International Holdings
DOYU
$130M
| $156K | ﹤0.01% |
13,097
-153
| -1% | -$2.27K |
2022 Q1
4 quarters
|
|
4970
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.02B
| $156K | ﹤0.01% |
+14,012
| New | +$156K |
2023 Q1
0 quarters
|
|
4971
Third Coast Bancshares
TCBX
$721M
| $156K | ﹤0.01% |
9,915
+420
| +4% | +$7.53K |
2021 Q4
5 quarters
|
|
|
OMIC
4972
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $156K | ﹤0.01% |
4,294
+1,244
| +41% | +$76.2K |
2021 Q2
7 quarters
|
|
4973
FT Vest US Equity Moderate Buffer ETF January
GJAN
$445M
| $155K | ﹤0.01% |
+5,010
| New | +$152K |
2023 Q1
0 quarters
|
|
|
IGD
4974
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$478M
| $155K | ﹤0.01% |
30,359
-14,028
| -32% | -$74.3K |
2022 Q4
1 quarter
|
|
4975
Regional Management Corp
RM
$303M
| $155K | ﹤0.01% |
5,964
+1,448
| +32% | +$44.8K |
2016 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.